ORTEXORTEX News
Live short interest, options flow, and signals — free on ORTEX.Sign up free →
Market Commentary

JP Morgan Sweeps Banks Higher; Medtech Faces Cuts

By ORTEX News · Edited by , Editor, ORTEX NewsUpdated 1 min read

Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish

ShareXLinkedInReddit

JP Morgan's equity desk was busy on Sunday. Analyst Vivek Juneja lifted price targets across six US bank stocks in a single sweep. WFC went to $92, USB to $65.50, TFC to $51.50, RF to $31, STT to $192.50 and PNC to $259. All six retain Hold or Sell ratings, so the moves reflect improved estimates rather than a change in conviction.

The most notable call in the sweep was on ARES. JP Morgan's Kenneth Worthington trimmed his target on Ares Management to $154 from $155. The stock sits in a sector where rising unemployment in Europe could weigh on credit conditions. Euro-area joblessness hit 6.5% in September 2026, the highest September reading in two years, according to ORTEX Alt Data.

On the waste-management side, JP Morgan raised its target on RSG sharply to $265 from $245, a $20 move while keeping a Hold rating. That gap between a bullish target and a cautious rating is the kind of setup worth watching.

SYK saw the consensus target edge down to $350.42 from $358.58. The medtech giant faces 23 analyst holds against just one buy, a distribution that leaves little room for positive surprises.

TROW also got a target bump from JP Morgan to $107, though the firm keeps a Sell rating. T. Rowe Price carries four sells in the consensus, a rare bearish skew for a major asset manager.

Stocks in this article

How this article was generated

Generated
1 Nov 2026, 00:20
Prompt version
v1.0
Data sources
Analyst consensusAlt DataIndex Rebalance

ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.